Taking PSA level, Gleason score, International Society of Urological Pathology (ISUP) stage, and tumor metastasis into consideration, this model still displayed acceptable sensitivity of over 90% in all groups, indicating a broad application scenario of this metabolic model (Figure S16). This evidence concerns the gene KLK3 and neoplasm.